AMAL Therapeutics

Abalos Therapeutics

This company develops arenavirus-based immuno-virotherapies to treat solid tumours and metastases for patients with cancer.

Nykode Therapeutics

This company develops immunotherapy vaccines to treat patients with cancer and autoimmune diseases.

Bactheravax

This company develops therapeutic vaccines targeting tumour-associated bacteria to improve treatment sensitivity and immune responses for patients with colorectal and other cancers.

Revealis Biotherapeutics

This company develops therapeutic cancer vaccines targeting immune-escaped and immunotherapy-resistant tumours for healthcare providers and patients.

IO Biotech

The company develops immune-modulating therapeutic cancer vaccines to treat patients with melanoma and other solid tumours.

Hubro Therapeutics

This company develops neoantigen-targeted cancer vaccines for patients with gastrointestinal cancers to activate anti-cancer specific T-cell immune responses.

AMYL THERAPEUTICS

The company develops pan-amyloid immunotherapies to treat patients with neurodegenerative and rare diseases caused by toxic protein aggregates.

Medici Therapeutics

The company develops personalised mRNA cancer vaccines and T cell therapies for patients to treat tumours and combat age-related cellular decline.